Should you buy INJ? Questions about INJ
Is it a good time to buy Injective today?
Supply and demand point to a mixed long-run signal for Injective (Oct 11 2026, score 6/10). Injective adds +1.03% new supply in 90 days, and demand reads strong (3.5/5). Injective's price drivers: 2 ▲ price up, 0 ▼ price down.
Is a US Injective ETF likely to launch soon?
Possibly before 2027. Two US INJ ETFs have updated their filings, and Injective's CEO expects a launch before then, but no date is set as of Oct 10 2026. We count it as a plus while new supply stays moderate, +1.03% in 90 days. Our supply-and-demand read for Injective stays mixed.
Is Injective dead, or do people still want it?
Far from dead on our numbers. Demand reads strong at 3.5/5 on Oct 10 2026, and both of Injective's price drivers point up. Supply is the softer side, growing about 4.17% over the next year. Our supply-and-demand read for Injective stays mixed.
Could Injective ever hit $100?
Injective trades near $7.58 (Oct 11 2026). $100 a coin means a $10B market cap, 13 times today's $758M. Injective's supply also grows +4.17% in the next year, so every extra coin needs buyers too. That leaves Injective's long-run signal at mixed, by supply and demand.
Is it time to take profit on Injective?
We would read Injective differently if new supply keeps arriving (+1.03% in 90 days), or demand falls from strong. Until then Injective's signal stays mixed. Mark this date for Injective: Before 2027 (CEO view) — First US INJ ETF?.
Is Injective a good investment right now?
Injective scores 6/10 on our framework (Oct 11 2026): supply 2.5/5 (moderate), demand 3.5/5. Over the next year Injective's supply changes +4.17%. The long-run signal is mixed.
How do I know when to buy Injective?
Supply and demand favor Injective most when little new supply is coming, demand is strong and the price drivers point up. Right now Injective has +1.03% new supply in 90 days (moderate), demand strong (3.5/5), drivers 2 ▲ / 0 ▼.
Will Injective go up in 2026?
Injective's price drivers today: 2 pointing up, 0 pointing down, out of 2. ▲ US INJ ETFs: Two US INJ ETFs updated filings; CEO expects launch before 2027. ▲ Pineapple INJ pile: Holds about 7.7M INJ; most is pledged as loan collateral.
Should I buy Injective or Bitcoin?
Injective: mixed signal, 6/10 · Bitcoin: positive signal, 8.5/10 (Oct 11 2026). By supply and demand, Injective reads weaker than Bitcoin today.
Every answer here applies basic economic theory — the law of supply and demand — to this coin's data. It is not financial advice. How we read every coin →
How does MrNasdog judge every coin, and why is +1.03% shown in red?
We look at two things, half each: supply and demand. Fewer new coins mean less selling pressure. A meme coin scores 1.5 at most on supply: its team got its coins for free, so no new supply does not make it safe. We also show each coin's age, with a warning when it is younger than 1 year. Demand looks at how much people want the coin now and how much buying could come later. Price Drivers (Beta) are the 2 or 3 things that can move one coin's price that supply and demand miss; they have no score. INJ supply grows +1.03% in the next 90 days, so it shows in red: more INJ reaches the market than is removed. Zero or falling supply is always green, any growth is red.
What do Watch INJ alerts cover?
One email before each big supply event, and the day our verdict changes. Nothing else. You can watch 2 coins for free.
More coins: CAKE · DASH · VET · Which crypto to buy now → · Embed this coin